Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-12-05
2010-06-08
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S220000, C514S229800, C514S359000, C514S375000, C514S394000, C514S406000, C514S411000, C540S488000, C540S557000, C544S101000, C548S218000, C548S256000, C548S302100, C548S359500, C548S430000
Reexamination Certificate
active
07732435
ABSTRACT:
The invention relates to novel heterocyclic compounds of the formulain which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their use as medicaments and to medicaments comprising them.
REFERENCES:
patent: 4419352 (1983-12-01), Cox et al.
patent: 2005121116 (2005-12-01), None
patent: WO 2005/121116 (2005-12-01), None
Edwards, J M, et al: “Antineoplastic activity and cytotoxicity of flavones, isoflavones, and flavanones” Journal of natural products, vol. 42, No. 1, 1979, pp. 85-91. p. 90; table 2.
Brain Christopher Thomas
Culshaw Andrew James
Dziadulewicz Edward Karol
Edwards Lee
Hart Terance William
Fierro Alicia L
Novartis AG
Shameem Golam M. M.
LandOfFree
Chromone derivatives useful as antagonists of VR1 receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chromone derivatives useful as antagonists of VR1 receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chromone derivatives useful as antagonists of VR1 receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4162450